Clinical Trial Update: A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301) [Phase 3]

View source ↗

Summary

Phase 3 EV-301 trial comparing enfortumab vedotin to standard chemotherapy in previously treated locally advanced or metastatic urothelial cancer has completed,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Cancer

Drugs mentioned

• Padcev (enfortumab vedotin)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Ureteral Cancer, Urothelial Cancer | Phase 3 | Status: COMPLETED | Results posted: 2021-08-24